Literature DB >> 17299464

Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis.

I Suda1, F Ishikawa, M Hatakeyama, M Miyawaki, T Kudo, K Hirano, A Ito, O Yamakawa, S Horiuchi.   

Abstract

OBJECTIVE: To examine the effect of purple sweet potato (PSP) beverage rich in acylated anthocyanins on serum hepatic biomarkers in healthy Japanese men.
DESIGN: A randomized, double-blind, placebo-controlled, parallel study.
SETTING: Kumamoto in Japan.
SUBJECTS: Healthy adult men (30-60 years) with borderline hepatitis who had one or more of serum gamma-glutamyl transferase (GGT), aspertate aminotransferase (AST) and alanine aminotransferase (ALT) levels over normal ranges, and who were negative for hepatitis virus were openly recruited by an advertisement. Of the 48 persons enrolled, 38 (mean age 43.0 years (30-54 years)) completed the study.
METHODS: The subjects were randomly assigned to the PSP group and the placebo group. During the 8-week intervention, the subjects in the PSP group consumed two bottles of the PSP beverage with acylated anthocyanins (200.3 mg anthocyanins per 125 ml per bottle) per day, and the subjects in the placebo group, two bottles of a placebo beverage (1.7 mg anthocyanins per 125 ml per bottle). All of the data measured were analyzed by two-way repeated measures analysis of variance (ANOVA) with groups and times. The data of the hepatic markers were analyzed using the Dunnett multiple comparison among the time points and t-test between groups at the same time point. Two-sided P<0.05 were defined as the level of significance.
RESULTS: Serum GGT, AST and ALT levels showed interactions (P<0.05) between the beverage groups and time; the others were not affected. The PSP beverage group showed lower hepatic marker levels than the placebo group during the ingestion period, particularly the GGT level (-14.1 IU/l, 95% Confidence intervel (CI) -25.4 to -2.7, P=0.017 at 2 weeks; -16.8 IU/l, 95% CI -36.2 to 2.5, P=0.081 at 4 weeks; -26.7 IU/l, 95% CI -47.6 to -5.7, P=0.014 at 6 weeks and -27.9 IU/l, 95% CI -49.9 to -5.9; P=0.014 at 8 weeks). No correlation between alcohol consumption and each hepatic biomarker level before and after the ingestion was observed.
CONCLUSION: The intake of the PSP beverage significantly decreased the serum levels of hepatic biomarkers, particularly the GGT level, in healthy men with borderline hepatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299464     DOI: 10.1038/sj.ejcn.1602674

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  17 in total

Review 1.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

2.  Double-blind, placebo-controlled pilot trial of anthocyanin-rich purple sweet potato beverage on serum hepatic biomarker levels in healthy Caucasians with borderline hepatitis.

Authors:  T Oki; M Kano; F Ishikawa; K Goto; O Watanabe; I Suda
Journal:  Eur J Clin Nutr       Date:  2016-08-17       Impact factor: 4.016

Review 3.  The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.

Authors:  Maria Del Ben; Licia Polimeni; Francesco Baratta; Daniele Pastori; Francesco Angelico
Journal:  Br J Clin Pharmacol       Date:  2016-03-04       Impact factor: 4.335

4.  The influences of purple sweet potato anthocyanin on the growth characteristics of human retinal pigment epithelial cells.

Authors:  Min Sun; Xiaoling Lu; Lei Hao; Tao Wu; Huanjiao Zhao; Chao Wang
Journal:  Food Nutr Res       Date:  2015-06-11       Impact factor: 3.894

5.  Genetic dissection of black grain rice by the development of a near isogenic line.

Authors:  Hiroaki Maeda; Takuya Yamaguchi; Motoyasu Omoteno; Takeshi Takarada; Kenji Fujita; Kazumasa Murata; Yukihide Iyama; Yoichiro Kojima; Makiko Morikawa; Hidenobu Ozaki; Naoyuki Mukaino; Yoshinori Kidani; Takeshi Ebitani
Journal:  Breed Sci       Date:  2014-06-01       Impact factor: 2.086

Review 6.  Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease.

Authors:  Maria Catalina Hernandez-Rodas; Rodrigo Valenzuela; Luis A Videla
Journal:  Int J Mol Sci       Date:  2015-10-23       Impact factor: 5.923

7.  A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.

Authors:  Pei-Wen Zhang; Feng-Xia Chen; Di Li; Wen-Hua Ling; Hong-Hui Guo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 8.  Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.

Authors:  Giuseppe Della Pepa; Claudia Vetrani; Gianluca Lombardi; Lutgarda Bozzetto; Giovanni Annuzzi; Angela Albarosa Rivellese
Journal:  Nutrients       Date:  2017-09-26       Impact factor: 5.717

Review 9.  Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Patrizia Riso; Alessandra Mazzocchi; Marisa Porrini; Silvia Fargion; Carlo Agostoni
Journal:  Oxid Med Cell Longev       Date:  2013-10-24       Impact factor: 6.543

10.  Effect of consuming a purple-fleshed sweet potato beverage on health-related biomarkers and safety parameters in Caucasian subjects with elevated levels of blood pressure and liver function biomarkers: a 4-week, open-label, non-comparative trial.

Authors:  Tomoyuki Oki; Mitsuyoshi Kano; Osamu Watanabe; Kazuhisa Goto; Esther Boelsma; Fumiyasu Ishikawa; Ikuo Suda
Journal:  Biosci Microbiota Food Health       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.